DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Levamlodipine
Levamlodipine
2018 Annual Results Presentation
2019 Chinese Guideline for the Management of Hypertension in the Elderly
Download
Short‑ and Long‑Term Treatment with Angiotensin‑Converting Enzyme
Levamlodipine)Tablets, for Oral Use
Pharmacokinetics, Pharmacodynamics
Drug Information Center Highlights of FDA Activities – 12/1/19 – 12/31/19
International Nonproprietary Names for Pharmaceutical Substances
Stembook 2018.Pdf
New Drug Approval
Appendix B - Product Name Sorted by Applicant
Non-Clinical Review(S)
Calcium Channel Ca2+ Channels; Ca Channels
Dose Optimization
INDIA Antihypertensive Drugs Market Factsheet
March/April 2020 Update: Changes to the Highmark
Conjupri (Levamlodipine), for the Treatment of Hypertension in Adults and Pediatric Patients 6 Years and Older, to Lower Blood Pressure
Drug Pipeline MONTHLY UPDATE
Top View
Orange Book Cumulative Supplement 12 December 2019
International Nonproprietary Names for Pharmaceutical Substances (INN)
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Orange Book Cumulative Supplement 09 September 2020
Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
Calcium Channel Blockers
Preventative Medication List
Drug Pipeline MONTHLY UPDATE
Standard Commercial Drug Formulary Prior Authorization Guidelines
1 SUPPLEMENTAL MATERIAL Blood Pressure-Lowering Interventions To
Appendix a - Product Name Index
Medical Necessity Criteria for Pharmacy Edits, 5.01.605
Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS
December 2019 New Drugs
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy In
210311 Wild Guided Report.Indd
Prescription Drug Formulary This Formulary Is for the Community Care Health’S Commercial Large Group and Small Group HMO Business
2021 Standard Opt out with ACSF
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Affinity and Specificity of Levamlodipine-Human Serum
Recent Approaches to Chiral 1,4-Dihydropyridines and Their Fused Analogues
2/28/19 Received Date(S) 2/28/19 PDUFA Goal Date 12/28/19 Division / Office Dcarp
WHO Drug Information Vol. 21, No. 2, 2007
Supplemental Information
CHANGES to the HIGHMARK DRUG FORMULARIES Following Is the Update to the Highmark Drug Formularies and Pharmaceutical Management Procedures for January 2021
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
January 2020
1408-JIMA-September-2020.Pdf
Drugs/Biologics Not Covered Unless Approved Under Medical Necessity Review Employer Group Plans: Standard, Performance, Or Legacy Prescription Drug List
Preferred Drug List (PDL)
7Th Brazilian Guideline of Arterial Hypertension
An Isomer with Difference—Time to Shift from Racemic Amlodipine
Prior Authorization Requirements for Select Drugs